Simplified Chlamydia trachomatis screening in France: positivity rate from a large community laboratory network in 2025
Prescription-free screening reached young adults with chlamydia at high rates and caught infections that standard testing alone would have missed.
This large retrospective laboratory-network screening study examined Simplified Chlamydia trachomatis screening in France: positivity rate from a large community laboratory network in 2025. Prescription-free testing reached many young adults with high positivity, and multisite sampling identified infections that urogenital testing alone would have missed.
What the study was
- Study design
- Large retrospective laboratory-network screening study
- Population
- People undergoing Chlamydia trachomatis screening in France
- Sample size
- 543,607 screenings
- Category
- Public Health
- Maturity
- Validated
- Journal
- Sexual health
Why it surfaced
Large retrospective laboratory-network screening study; Prescription-free testing reached many young adults with high positivity, and multisite sampling identified infections that urogenital testing alone would have missed. Score kept conservative because only the PubMed abstract and metadata were reviewed.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.